Trial Profile
Pharmacogenetic Investigation of Naltrexone
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Naltrexone (Primary)
- Indications Smoking withdrawal
- Focus Pharmacogenomic; Therapeutic Use
- 20 Dec 2013 New trial record